India Neurovascular Devices Market, By Device (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices), By Therapeutic Application (Stroke, Cerebral Artery, Cerebral Aneurysm, Others), By End User (Hospitals, Specialty Clinics, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

India Neurovascular Devices Market was valued at USD 202.95 Million in 2024 and is expected to reach USD 322.43 Million by 2030 with a CAGR of 7.98%. The India Neurovascular Devices Market is entering a phase of strategic acceleration, underpinned by the sharp rise in cerebrovascular conditions particularly stroke which now rank among the leading causes of mortality and long-term disability nationwide. This evolving disease landscape is driving sustained demand for advanced, minimally invasive neuro-interventional solutions, reshaping both clinical practices and procurement strategies across major healthcare institutions.

India’s market is approaching a structural pivot, where clinical urgency, technological progress, and rising procedural volumes are converging. The increasing preference for device-based stroke interventions, such as thrombectomy and coil embolization, is prompting hospitals to expand neuro-interventional capacity and invest in high-precision devices and imaging platforms. However, barriers around cost sensitivity, uneven geographic access, and limited neurology-trained professionals continue to constrain full-scale adoption.

Despite these systemic limitations, momentum is built driven by a combination of public and private capital investments, growing insurance coverage through programs like Ayushman Bharat, and the expansion of stroke-ready centers in tier-1 and tier-2 cities. These developments are setting the stage for robust mid- to long-term market expansion, positioning India as a strategic growth hub for global neurovascular device manufacturers seeking scalable opportunities in high-burden emerging markets.

Key Market Drivers

Rising Burden of Neurological Disorders and Stroke

The increasing prevalence of neurological disorders is a primary catalyst for the neurovascular devices market. According to the Global Burden of Disease (GBD) study published in The Lancet Neurology (2024), India is facing a significant surge in stroke incidence, with new cases rising from approximately 650,000 in 1990 to over 1.25 million annually in the current decade. This transition has been accelerated by metabolic risk factors, notably high systolic blood pressure and ambient air pollution, which now account for a substantial portion of the national stroke-related disability burden.

While the prevalence of neurological disorders in India remains high, ranging from 3.0 to 11.9 cases per 1,000 people, the clinical profile is shifting toward younger and middle-aged adults. This demographic shift has intensified the demand for specialized interventions such as mechanical thrombectomy and coil embolization. Hospitals in tier-1 and tier-2 cities are responding by establishing dedicated stroke units and adopting advanced microcatheters and flow diverters to manage complex cases. The ICMR's "Stroke Care Pathway" and the recently established PRAAN registry, India's first multicentric prospective registry for mechanical thrombectomy, highlight a national move toward standardized, device-driven neuro-interventional care.

Increasing Awareness and Early Diagnosis

Market growth is further supported by a nationwide emphasis on the "golden hour" for stroke treatment. Public health initiatives, such as the "Stroke Pe Rok" campaign and the "Act FAST" protocol promoted by the Indian Stroke Association, have significantly improved the rate of timely hospital arrivals. The 2025 World Stroke Day theme, "Every Minute Counts," underscores this urgency, emphasizing that rapid diagnosis through CT angiography and MRI is essential for eligibility in minimally invasive procedures.

The government’s commitment to a "hub-and-spoke" model for stroke care ensures that even peripheral hospitals can stabilize patients before transferring them to advanced centers for mechanical clot removal. A breakthrough in this space is the 2024 DCGI approval of indigenous devices like the Supernova thrombectomy system. This development of local, cost-effective alternatives is expected to increase the accessibility of high-end neurovascular treatments across both public and private sectors. As diagnostic accuracy improves and awareness of recovery outcomes grows, the adoption of advanced neurovascular infrastructure has reached a 51% rise in procedural volume compared to the previous decade, marking a permanent shift in India’s clinical landscape.

Download Free Sample Report

Key Market Challenges

High Cost of Neurovascular Devices and Limited Insurance Coverage

The cost of neuro-interventional care in India remains a significant hurdle, primarily because the majority of advanced devices, such as stent retrievers, flow diverters, and embolization coils, are imported. This reliance on global supply chains leads to high acquisition costs. 

While the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) has authorized over 10.98 crore (109.8 million) hospital admissions as of December 2025, the scheme’s annual cap of INR 5 lakhs per family often barely covers the cost of high-end neurovascular implants alone, excluding intensive care and rehabilitation. Consequently, access to these life-saving technologies is frequently limited to high-income individuals or those with premium private insurance. For the broader population, the "out-of-pocket" expenditure for neuro-interventions remains catastrophic, as private insurance penetration is still maturing and often includes restrictive clauses for "advanced" or "robotic-assisted" neuro-procedures.

Distribution of Skilled Workforce and Infrastructure

India faces a critical disparity in the availability of the specialized medical workforce required for neurovascular interventions. According to data from the Neurological Society of India, there are approximately 1,800 to 2,500 qualified neurosurgeons for a population exceeding 1.4 billion. This shortage is even more acute for interventional neurologists, who are concentrated almost exclusively in metro and tier-1 cities. Public health data shows that 80% of specialist doctors reside in urban areas, leaving nearly 700 million rural residents with a significant "travel burden" of 75–100 km to reach a tertiary care center.

While the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PM-ABHIM) has allocated INR 64,180 crore through 2026 to strengthen district-level care, the current reality is that a large volume of stroke and aneurysm patients are referred too late to benefit from device-based interventions. Without a massive scale-up in specialized residency training and the decentralization of high-resolution neuroimaging, the benefits of neurovascular technology will remain confined to elite urban clusters.

Key Market Trends

Expansion of Neuro-Interventional Infrastructure in Tier 2 and Tier 3 Cities

Historically, neurovascular procedures in India have been concentrated in top-tier private hospitals in metropolitan areas. However, recent years have seen a decentralization of neurological care, with public and private stakeholders expanding interventional infrastructure into emerging urban clusters and state-level medical colleges.

Leading healthcare providers and hospital chains are investing in stroke units, advanced neuroimaging equipment, and interventional radiology suites in secondary cities. This is increasing the installed base for neurovascular devices and enhancing geographic access to critical neurological care. As awareness and clinical training spread, and device manufacturers form partnerships with regional hospitals, device penetration in semi-urban India is expected to multiply, tapping into a previously under-served patient population.

Technological Advancements and Growing Domestic Manufacturing

Innovation in neurovascular device technology is transforming treatment protocols. The market is witnessing the introduction of next-generation materials, enhanced catheter flexibility, microcatheters for deep vessel access, and precision-guided navigation systems. Additionally, India is beginning to witness growth in local manufacturing and R&D, supported by government initiatives such as ‘Make in India’ and the PLI scheme for medical devices.

These advancements are improving clinical outcomes, procedural efficiency, and reducing overall treatment costs. Domestic manufacturing is also improving supply chain reliability and enabling more cost-effective pricing models tailored to Indian hospitals. As Indian manufacturers scale operations and global players expand their R&D footprints in India, the country is likely to emerge not just as a consumption hub, but also as a manufacturing and export base for neurovascular technologies.

Segmental Insights

Therapeutic Application Insights

Based on the category of Therapeutic Application, the Stroke segment emerged as the fastest growing segment in the India Neurovascular Devices Market in 2024. India is witnessing a sharp increase in both ischemic and hemorrhagic strokes, driven by lifestyle-related risk factors such as hypertension, diabetes, sedentary habits, and poor dietary patterns. Notably, strokes are increasingly affecting younger populations, particularly in urban and semi-urban regions. This epidemiological shift is pushing the demand for timely and effective neurovascular interventions.

Several Indian states, along with the central government, are prioritizing stroke as a public health emergency. Initiatives under programs like the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) are enhancing early screening, diagnosis, and emergency response infrastructure creating a conducive environment for device-based stroke management. The introduction and widespread clinical adoption of mechanical thrombectomy, stent retrievers, aspiration catheters, and balloon occlusion devices have revolutionized stroke care. These technologies allow for minimally invasive procedures with faster recovery and reduced morbidity. Major hospitals in metro and tier-1 cities are rapidly equipping neuro-interventional departments to manage acute stroke cases effectively. These factors are expected to drive the growth of this segment.

Download Free Sample Report

Regional Insights

South India emerged as the largest market in the India Neurovascular Devices Market in 2024, holding the largest market share in terms of value. South India, particularly cities like Bengaluru, Chennai, Hyderabad, and Kochi, hosts a significant number of multi-specialty hospitals, tertiary care centers, and neurology-focused institutes. These healthcare hubs are well-equipped with state-of-the-art neuro-interventional radiology and neurosurgical infrastructure, enabling faster adoption of advanced neurovascular devices such as coiling systems, stent retrievers, and flow diverters. The region is home to several high-volume centers of excellence in neurology and interventional neuroradiology. Moreover, South India has a strong presence of trained neurologists, interventional radiologists, and neurosurgeons, many of whom participate in clinical trials, device evaluations, and early adoption of next-gen technologies further driving regional demand.

Cities like Chennai and Bengaluru attract a significant number of domestic and international medical tourists seeking advanced neuro-interventions, particularly for stroke management, aneurysms, and arteriovenous malformations (AVMs). This influx sustains high procedure volumes and supports continuous procurement and utilization of neurovascular devices. The literacy rate, health awareness, and early diagnosis levels are comparatively higher in South India. This leads to early referrals and timely intervention in neurological cases such as ischemic stroke, thereby increasing the procedural volumes that require neurovascular devices.

Recent Developments

• In January 2026, Stryker appointed Spencer Stiles as President and COO, effective January 1, 2026. This move is significant for the Indian market as Stiles will oversee global M&A and strategy, following Stryker’s 2024–2025 expansion of its Global Technology Centre (SGTC) in Gurgaon, which now conducts rigorous life-cycle testing for neurovascular devices.
• In December 2025 The Supernova Stent Retriever, developed by Gravity Medical Technology, was approved by the CDSCO. This is the first stroke device approved in India based exclusively on domestic clinical trial data (the GRASSROOT trial led by AIIMS Delhi).
• In November 2024, Philips India launched its next-generation Azurion interventional platform, targeting specialists across neurology, cardiology, vascular, and surgical disciplines. Engineered to optimize workflow efficiency in complex neurovascular procedures, the system integrates advanced C-arm rotation and enhanced angulation capabilities, enabling precise imaging from multiple angles. The platform is designed to support care teams in accelerating clinical decision-making, increasing procedural throughput, and improving patient outcomes, positioning it as a high-value solution in India’s rapidly evolving interventional care landscape.

Key Market Players

• Stryker
• Medtronic
• Terumo India Private Limited
• Medical Device Business Services, Inc
• Penumbra, Inc.
• B. Braun SE
• Integra LifeSciences Corporation
• Acandis India Pvt. Ltd
• MicroPort Scientific Corporation

Report Scope:

In this report, the India Neurovascular Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Neurovascular Devices Market, By Device:

o   Cerebral Embolization and Aneurysm Coiling Devices

o   Cerebral Angioplasty and Stenting Systems

o   Neurothrombectomy Devices

o   Support Devices

o   Trans Radial Access Devices

• India Neurovascular Devices Market, By Therapeutic Application:

o   Stroke

o   Cerebral Artery

o   Cerebral Aneurysm

o   Others

• India Neurovascular Devices Market, By Therapeutic End User:

o   Hospitals

o   Specialty Clinics

o   Others

• India Neurovascular Devices Market, By Region:

o   North India

o   East India

o   West India

o   South India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Neurovascular Devices Market.

Available Customizations:

 India Neurovascular Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).